ProQR to Present at the Deutsche Bank Health Care Conference

By GlobeNewswire,  April 20, 2017, 07:00:00 AM EDT


LEIDEN, the Netherlands, April 20, 2017 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR) today announced that Gerard Platenburg, Chief Innovation Officer, will present at the 42nd Annual Deutsche Bank Health Care Conference on Wednesday, May 3, 2017 at 12:50pm ET. The conference is being held at the InterContinental Boston Hotel in Boston, MA, USA.

The live and archived webcast of the presentation will be accessible from the ‘Investor Relations' section of ProQR's website (www.proqr.com) under ‘Events and Presentations'. The archived webcasts will be available for 30 days following the presentation date.

About ProQR

ProQR Therapeutics is dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis Type 10 and dystrophic epidermolysis bullosa. Based on our unique proprietary RNA repair platform technologies we are growing our pipeline with patients and loved ones in mind. 

*Since 2012* 

Contact:

Smital Shah

Chief Financial Officer

T: +1 415 231 6431

ir@proqr.com

Source: ProQR Therapeutics

This article appears in: News Headlines

Referenced Stocks: PRQR


Latest News Video





Most Active by Volume

Company Last Sale Change Net / %
BAC $ 23.98 0.35 ▲ 1.48%
AKS $ 6.40 0.72 ▼ 10.11%
ABX $ 16.89 2.15 ▼ 11.29%
FCX $ 13.10 0.87 ▲ 7.11%
AKRX $ 33.09 0.37 ▲ 1.13%
CHK $ 5.51 0.13 ▲ 2.42%
T $ 39.94 0.08 ▼ 0.20%
GE $ 29.45 0.10 ▼ 0.34%

As of 4/25/2017, 04:15 PM